Kala Pharmaceuticals Inc. (KALA)
NASDAQ: KALA
· Real-Time Price · USD
8.08
0.01 (0.12%)
At close: Aug 15, 2025, 12:46 PM
Kala Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.15M | -8.95M | -8.18M | -8.95M | -9.58M | -11.81M | -8.63M | -8.7M | -10.41M | -14.46M | -12.84M | 29.07M | -28.11M | -32.94M | -47.57M | -28.13M | -36.5M | -30.41M |
Depreciation & Amortization | 67K | 68K | 69K | 63K | 61K | 66K | 70K | 79K | 77K | 77K | 80K | 151K | 149K | 157K | 212K | 259K | 256K | 248K |
Stock-Based Compensation | 2.24M | 2.31M | 2.09M | 2.04M | 1.88M | 2.38M | 2.37M | 2.4M | 1.36M | 1.32M | 960K | 1.33M | 1.92M | 2.81M | 2.75M | 3.93M | 4.71M | 4.7M |
Other Working Capital | 967K | -2.85M | 1.11M | 1.24M | -1.98M | -1.86M | -2.31M | 3.63M | 886K | 971K | -1.55M | n/a | -1.36M | 1.83M | 210K | -4M | 5.78M | -3.82M |
Other Non-Cash Items | 420K | 297K | 386K | 839K | 468K | 567K | 3.05M | -5.63M | 621K | 1.96M | 1.41M | 418K | -212K | 674K | 19.71M | 1.03M | 956K | 807K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14K | -14K | 5.41M | 10K |
Change in Working Capital | 694K | -2.55M | 1.03M | 1.29M | -2.05M | -2.05M | -2.18M | 8.9M | 758K | 1.41M | -3.34M | -2.22M | 839K | 5.22M | -3.02M | -3.16M | 3.56M | -8M |
Operating Cash Flow | -7.73M | -8.82M | -4.6M | -4.72M | -9.21M | -10.84M | -7.7M | -2.95M | -7.59M | -9.68M | -13.73M | -15.66M | -25.42M | -24.09M | -27.9M | -26.08M | -21.61M | -32.64M |
Capital Expenditures | n/a | n/a | -69K | 49K | -36K | -13K | -7K | -281K | -214K | -108K | -22K | -38K | -172K | -81K | -12K | -329K | -326K | -219K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | n/a | -62.91M | n/a | n/a | n/a | -4.61M | 50K | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.87M | n/a | 9.98M | n/a | n/a | -4.99M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | -47K | n/a | -5M | 2M | 3M | n/a | -76.25M | 5M | 23M | 48.25M |
Other Investing Acitivies | n/a | n/a | n/a | -139K | n/a | n/a | n/a | n/a | 47K | n/a | 58M | n/a | n/a | -255K | 71.64M | 50K | n/a | -243K |
Investing Cash Flow | -16K | n/a | -69K | -90K | -36K | -13K | -7K | 9.72M | -10.03M | -108K | 51K | 64.91M | 2.83M | -5.07M | -4.62M | 4.72M | 22.67M | 48.03M |
Debt Repayment | -2.5M | -28K | -5.03M | -18K | n/a | n/a | n/a | n/a | n/a | -10M | -10K | -40.01M | -10K | -9K | -9K | -9K | -236K | -9K |
Common Stock Repurchased | n/a | 13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -30K | n/a | n/a | 56K | n/a | -98K | 1.97M | n/a | n/a | -2.04M | n/a | n/a | n/a | 163K | n/a | 906K | 64K | 615K |
Financial Cash Flow | -2.53M | -135K | 6.65M | -180K | 14.97M | 8.44M | 2.54M | 40K | 3.07M | 2.86M | 31.79M | -39.87M | -10K | 154K | 160K | 1.23M | 5.85M | 35.31M |
Net Cash Flow | -10.28M | -8.96M | 1.98M | -5M | 5.72M | -2.42M | -5.17M | 6.81M | -14.55M | -6.93M | 18.1M | 9.37M | -22.6M | -29.01M | -32.37M | -20.13M | 6.92M | 50.71M |
Free Cash Flow | -7.73M | -8.82M | -4.67M | -4.68M | -9.25M | -10.86M | -7.7M | -3.23M | -7.81M | -9.79M | -13.76M | -15.7M | -25.59M | -24.17M | -27.92M | -26.41M | -21.93M | -32.86M |